foxo4-dri senolytic 2023 2024 Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis ES2 rapidly destroys TP53-FOXO4 foci
ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram Targeting Senescence: A Review of Senolytics and Senomorphics in Anti Aging Interventions The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Senolytic Drugs Market to Reach USD 667.6 Million by 2033
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



